Abstract
An increased incidence of cardiovascular disease has been found in rheumatic disorders. Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children. Prolonged immunological inflammatory process leads these patients to an early onset of atherosclerosis. We aimed to assess the presence of early vascular dysfunction in patients with systemic onset juvenile idiopathic arthritis (sJIA) and investigate the role of therapy sJIA in vascular health. Thirty-three patients (22 males, 11 females) diagnosed with sJIA according to the International League of Associations for Rheumatology criteria were compared to 72 age- and sex-matched controls. None of the participants was overweight, obese, or had a history of hypertension, dyslipidemia, diabetes mellitus, or cardiovascular disease. Arterial stiffness (As) was evaluated by measurement of carotid-femoral pulse wave velocity (PWV) and augmentation index (AIx) with a Vicorder. The mean age of patients in this study was 9.96 ± 3.71 years (range 4–16 years) and the mean age of controls was 10.9 ± 3.52 years (range 4–19 years). These two groups were well matched for age, sex, and BMI. The mean age of patients at the onset of disease was 7.06 ± 3.9 years (range 3–15 years). The mean duration of disease and active disease was 79 ± 45 months (range 6–162 months) and 58 ± 49 months (range 1–101 months), respectively. The highest levels of PWV and AIx were found in the patient group. Seven patients had had macrophage activation syndrome at presentation. In these patients, vascular changes were higher than other patients (6.30 ± 0.42 m/s vs 5.17 ± 0.55 m/s, p = 0.01, respectively). The corticosteroid therapy was found associated with higher PWV, (p < 0.05), while there was no difference between vascular parameters and use of non-steroid therapies (methotrexate (MTX), anti-TNF alfa agents). We also find statistically significant correlation between PWV and disease duration (p = 0.003, r = 0.45). Vascular function is impaired in patients with sJIA at a very young age. Vascular dysfunction may be partly attributed to the effects of disease-related characteristics (inflammation, disease activity, and medications).
Similar content being viewed by others
References
Cassidy J, Petty R (2011) Chronic arthritis in childhood. In: Cassidy J, Petty R, Laxer R, Lindsley C (eds) The textbook of pediatric rheumatology, 5th edn. Sauders Elsevier, Philadelphia, pp 206–208
Pieringer H, Pichler M (2011) Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications. QJM 104:13–26
Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55:1318–1327
Roifman I, Beck PL, Anderson TJ, Eisenberg MJ, Genest J (2011) Chronic inflammatory diseases and cardiovascular risk: a systematic review. Can J Cardiol 27:174–182
Gorska A, Rutkowska-Sak L, Musiej-Nowakowska E, Chlabicz S, Gorski S (2010) Nailfold videocapillaroscopy—a useful tool for screening patients with juvenile idiopathic arthritis at the risk of development of premature atherosclerosis. Postepy Hig Med Dosw (Online) 64:296–302
Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, Stern DM (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527–3561
Urbina EM, Williams RV, Alpert BS, Collins RT, Daniels SR, Hayman L et al (2009) American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young: noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension 54:919–950
Chen CY, Tsao CH, Ou LS, Yang MH, Kuo ML, Huang JL (2002) Comparison of soluble adhesion molecules in juvenile idiopathic arthritis between the active and remission stages. Ann Rheum Dis 61:167–170
De Benedetti F, Vivarelli M, Pignatti P, Oliveri M, Massa M, Pistorio A et al (2000) Circulating levels of soluble E-selectin, P-selectin and intercellular adhesion molecule-1 in patients with juvenile idiopathic arthritis. J Rheumatol 27:2246–2250
Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J et al (2004) International League of Associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392
Ross R (1999) Mechanisms of disease: atherosclerosis—an inflammatory disease. NEJM 340:115–126
Jednacz E, Rutkowska-Sak L (2012) Atherosclerosis in juvenile ıdiopathic arthritis. Mediators of Inflammation 1–5
Cesari M, Penninx BW, Newman AB et al (2003) Inflammatory markers and cardiovascular disease (The health, aging and body composition [health ABC] study). Am J Cardiol 92:522–528
Rho YH, Chung CP, Oeser A et al (2009) Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum 61:1580–1585
Sikora KA, Grom AA (2011) Update on the pathogenesis and treatment of systemic idiopathic arthritis. Curr Opin Pediatr 23:640–646
Lin YT, Wang CT, Gershwin ME, Chiang BL (2011) The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmun Rev 10:482–489
Stoner L, Young JM, Fryer S (2012) Assessments of arterial stiffness and endothelial function using pulse wave analysis. Int J Vasc Med 2012:1–9
Aatola H, Hutri-Kahonen N, Juonala M, Viikari JS, Hulkkonen J, Laitinen T et al (2010) Lifetime risk factors and arterial pulse wave velocity in adulthood: the cardiovascular risk in young Finns study. Hypertension 55:806–811
Sozeri B, Deveci M, Dincel N, Mir S (2013) The early cardiovascular changes in pediatric patients with systemic lupus erythematosus. Pediatr Nephrol 28(3):471–476
Chow PC, Ho MH, Lee TL, Lau YL, Cheung YF (2007) Relation of arterial stiffness to left ventricular structure and function in adolescents and young adults with pediatric-onset systemic lupus erythematosus. J Rheumatol 34:1345–1352
Argyropoulou MI, Kiortsis DN, Daskas N, Xydis V, Mavridis A, Efremidis SC et al (2003) Distensibility and pulse wave velocity of the thoracic aorta in patients with juvenile idiopathic arthritis: an MRI study. Clin Exp Rheumatol 21:794–797
Aulie HA, Selvaag AM, Günther A, Lilleby V, Molberg Ø, Hartmann A et al (2015) Arterial haemodynamics and coronary artery calcification in adult patients with juvenile idiopathic arthritis. Ann Rheum Dis 74:1515–1521
Vlahos AP, Theocharis P, Bechlioulis A, Naka KK, Vakalis K, Papamichael ND et al (2011) Changes in vascular function and structure in juvenile idiopathic arthritis. Arthritis Care Res 63:1736–1744
Martini A (2012) Systemic ıdiopathic arthritis. Autoimmun Rev 12:56–59
De Groot L, Posthumus MD, Kallenberg CG, Bijl M (2010) Risk factors and early detection of atherosclerosis in rheumatoid arthritis. Eur J Clin Investig 40:835–842
Rho YH, Solus J, Raggi P, Oeser A, Gebretsadik T, Shintani A, Stein CM (2011) Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Care Res 63(4):535–541
Weiss G, Willeit J, Kiechl S, Fuchs D, Jarosch E, Oberhollenzer F et al (1994) Increased concentrations of neopterin in carotid atherosclerosis. Atherosclerosis 106(2):263–271
Erren M, Reinecke H, Junker R, Fobker M, Schulte H, Schurek JO et al (1999) Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 19(10):2355–2363
Bulkley BH, Roberts WC (1975) The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsies patients. Am J Med 58:243–264
Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69(2):325–331
Choy E, Ganeshalingam K, Semb AG, Szekanecz Z, Nurmohamed M (2014) Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment. Rheumatology (Oxford) 53(12):2143–2154
Acknowledgments
The authors have received no external financial support to the work presented here.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Written informed consent was obtained from the parents, and the participants provided assent. The study was approved by the Ethics Committee of the Ege University and complied with the Declaration of Helsinki.
Disclosures
None.
Conflict of interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Sozeri, B., Atikan, B.Y., Ozdemir, K. et al. Assessment of vascular function in systemic onset juvenile idiopathic arthritis. Clin Rheumatol 35, 1699–1703 (2016). https://doi.org/10.1007/s10067-016-3254-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-016-3254-5